Reece, D E <br/><br/>
Interim analysis of the use of the anti-idiotype breast cancer vaccine 11D10 (TriAb) in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer.  [electronic resource] 

 -  Clinical breast cancer  Apr 2001 
 - 52-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1526-8209 
<br/><br/><label>Standard No.: </label>10.3816/CBC.2001.n.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Anti-Idiotypic--immunology<br/>Antibodies, Monoclonal<br/>Breast Neoplasms--immunology<br/>Cancer Vaccines--therapeutic use<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Glycolipids--immunology<br/>Glycoproteins--immunology<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Immunity, Cellular<br/>Lipid Droplets<br/>Lymphocyte Activation<br/>Middle Aged<br/>Survival Rate<br/>T-Lymphocytes--immunology<br/>Transplantation, Autologous<br/>Treatment Outcome